Silexion Therapeutics Corp - 8-K Filing
Silexion Therapeutics announces 1-for-24 reverse share split to regain Nasdaq compliance (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits (d) Exhibits 99)
Tickers: $SLXN
Read the full article at SEC EDGAR
Part of the story Faeth Therapeutics, Inc. - 8-K Filing (3 articles)